Clinical significance of coated extracorporeal circuits: A review of novel technologies

Perfusion

Volumn 19, Issue SUPPL. 1, 2004, Pages

  Gunaydin, Serdar ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC ACID ETHYL ESTER; BIOMATERIAL; HEPARIN; HUMAN ALBUMIN; LIQUEMINE; PHOSPHORYLCHOLINE; PROTAMINE;

BIOCOMPATIBILITY; CARDIOPULMONARY BYPASS; COMPARATIVE STUDY; EXTRACORPOREAL CIRCULATION; HEART PERFUSION; HUMAN; IN VITRO STUDY; MATERIAL COATING; MEDICAL DOCUMENTATION; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SURGICAL TECHNIQUE;

EID: 2342667614     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659104pf718oa     Document Type: Review

References (21)

1. Janvier G, Baquey C, Roth C, Benillan N, Belisle S, Hardy JF. Extracorporeal circulation, hemocompatibility, and biomaterials. Ann Thorac Surg 1996; 62: 1926-34.
2. Courtney JM, Zhao XB, Quian H, Sharma A. Modification of polymer surfaces: optimization of approaches. Perfusion 2003; 18: 33-39.
3. Engbers GH, Feijen J. Current techniques to improve the blood compatibility of biomaterial surfaces. Int J Artif Organs 1991; 14: 199-215.
4. Gott VL, Whitten JD, Dutton RC. Heparin bonding on colloidal graphite surfaces. Science 1963; 142: 1297-98.
5. Wendel HP, Ziemer G. Coating techniques to improve hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 1999; 16: 342-50.
6. Sinci V, Kalayciůglu S, Gunaydin S et al. Evaluation of heparin-coated circuits with full heparin dose strategy. Ann Thorac Cardiovasc Surg 1999; 5: 156-63.
7. Griffith KE, Vasquez MR, Beckly PD, Lalone BJ. Predicting oxygenator clinical performance from laboratory in vitro setting. J Extra Corpor Technol 1994; 26: 114-20.
8. Tanaka M, Motomura T, Kawada M et al. Blood compatible aspects of poly(2-methoxyethylacrylate) relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterials 2000; 21: 1471-81.
9. Gu YJ, Boonstra PW, Rijnsburger AA et al. Cardiopulmonary bypass circuit treated with surface modifying additives: a clinical evaluation of blood compatibility. Ann Thorac Surg 1998; 65: 1342-47.
10. Gourlay T. Biomaterial development for cardiopulmonary bypass. Perfusion 2001; 16: 381-90.
11. Stammers AH. Biocompatibility of Trillium biopassive surface coated oxygenator during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2001; 15: 539-41.
12. Mahoney GB. Heparin bonded circuits: clinical outcomes and costs. Perfusion 1998; 13: 192-204.
13. Gunaydin S, Farsak B, Kocakulak M, Sari T, Yorgancioglu C, Zorlutuna Y. Clinical performance and biocompatibility of poly (2-methoxyethylacrylate) coated extracorporeal circuits. Ann Thorac Surg 2002; 74: 819-24.
14. Kocakulak M, Kocum C, Saber R et al. Investigation of blood compatibility of PMEA coated extracorporeal circuits. J Bioact Compat Poly 2002; 17: 343-56.
15. Tevaearai HT, Mueller XM, Seigneul I et al. Trillium coating of cardiopulmonary bypass circuits improves biocompatibility. Int J Artif Organs 1999; 22: 629-34.
16. Ereth MH, Nuttall GA, Clarke SH et al. Biocompatibility of Trillium biopassive surface coated oxygenator versus uncoated oxygenator during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2001; 15: 545-50.
17. De Somer F, Francois K, van Oeveren W. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. Eur J Cardiothorac Surg 2000; 18: 602-606.
18. Courtney JM, Lamba NMK, Gaylor JDS, Ryan CJ, Lowe GDO. Blood contacting biomaterials: bioengineering viewpoints. Artif Organs 1995; 19: 852-56.
19. Vijay V, McCusker K. Recent advances in biocompatible surface-modifying additives for cardiopulmonary bypass. Perfusion 2003; 18: 41-45.
20. Harig F, Hohenstein B, von der Emde J et al. Modulating IL-6 and IL-10 levels of pharmacologic strategies and the impact of different extracorporeal circulation parameters during cardiac surgery. Shock 2001; 16: 33-38.
21. Rega FR, Vandezande EJ, Jannis NC, Verleden GM, Lerut TE, Van Raemdonck D. The role of leukocyte depletion in ex vivo evaluation of pulmonary grafts from non-heart beating donors. Perfusion 2003; 18: 13-21.